作为神经退行性疾病和抑郁症的多重目标天然产品的灵:最近的观点
Zhibei Li1, Yu Zheng1, Kai Liu1
1State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Phytotherapy research : PTR
|September 5, 2023
概括
林是一种来自中国草药的天然化合物,有望治疗神经退行性疾病和抑郁症. 需要进一步的研究来支持它们的临床使用,因为它们具有抗氧化和抗炎作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 自然产品 自然产品
背景情况:
- 全球人口老龄化增加了对神经退行性疾病有效治疗的需求.
- 自然产品,特别是来自中国草药的林,因其生物活性而受到越来越多的关注.
- 林根植物已经证明了对神经退行性疾病和抑郁症的神经保护作用.
研究的目的:
- 审查类药物的药理作用,药理动力学,安全性和临床试验.
- 总结关于神经退行性疾病和抑郁症的灵的科学文献.
- 评估林格南作为神经疾病治疗药物的潜力.
主要方法:
- 关于类素和神经保护的科学文章的文献综述.
- 关于利格南的药理活性,药理动力学和安全性的研究摘要.
- 分析可用的临床试验数据,以林格南为基础的治疗.
主要成果:
- 类植物具有显著的抗氧化和抗炎性质.
- 潜在的神经保护机制包括抗亡,神经系统调节和突触调节.
- 有证据表明,在神经退行症和抑郁症的临床前模型中,基素是有效的.
结论:
- 在治疗神经退行性疾病和抑郁症方面,Lignans显示出相当大的神经保护潜力.
- 目前的证据不足以直接临床应用.
- 灵类药物代表了未来神经病学药物开发的有希望的候选人.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
270
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
270
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Long-term Depression
31.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.0K
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Anxiolytic Drugs: Overview
349
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
349


